Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI)
Nuclear research and training · HORIZON-IA · TRL 5–7 · Needs partners
What this call funds
This call funds projects that develop and scale up EU-based production of stable isotopes (especially Yb-176) needed to manufacture medical radioisotopes used in cancer therapies like Lutetium-177 treatments. The goal is to reduce the EU's dependence on imports (mainly from Russia) and build a secure, resilient European supply chain for nuclear medicine. Activities should focus on prototyping, testing, piloting and scaling production processes, with limited research allowed.
nuclear energy · medical devices · digital health · advanced materials · deep tech
Who wins this
This call best suits consortia of industrial players, research organisations and nuclear science experts aiming to demonstrate and scale up European production of medical-grade stable isotopes for nuclear medicine.
Could you win this call?
We read your site to see what you build.
The call in detail
- Indicative grant size
- €2M
- Funding model
- Lump sum — paid per completed work package, no financial reporting of actual costs
- Submission
- Single-stage submission (full proposal at once)
- Type of action
- HORIZON Innovation Actions
- Partners
- Required. The call asks for a consortium — a group applying together, typically 3+ organisations from 3+ countries.
- Also required
- The Joint Research Centre (JRC) may participate as a member of the funded consortium, bearing its own operational costs; funding is provided as a lump sum.
- Eligible countries (45)
- Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Norway, Iceland, Switzerland, United Kingdom, IL, TR, UA, RS, MK, ME, AL, BA, XK, GE, AM, MD, TN, NZ
Read the full conditions from the official call ›
General conditions 1. Admissibility conditions: Proposal page limit and layout described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes. Proposal page limits and layout: described in Part B of the Application Form available in the Submission System. 2. Eligible countries described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide. 3. Other Eligibility Conditions The Joint Research Centre (JRC) may participate as member of the consortium selected for funding. described in Annex B of the Work Programme General Annexes. 4. Financial and operational capacity and exclusion described in Annex C of the Work Programme General Annexes. 5a. Evaluation and award: Award criteria, scoring and thresholds described in Annex D of the Work Programme General Annexes. 5b. Evaluation and award: Submission and evaluation processes described in Annex F of the Work Programme General Annexes and the Online Manual. 5c. Evaluation and award: Indicative timeline for evaluation and grant agreement described in Annex F of the Work Programme General Annexes. 6. Legal and financial set-up of the grants Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf ]]. described in Annex G of the Work Programme General Annexes. Specific conditions described in the topic conditions
Who has won calls like this
No past winners are recorded for this call family yet.